4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Celcuity Inc. (CELC) operates in the Biotechnology industry and is headquartered in Minneapolis, United States with about 155 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, CELC reported $0M in revenue and ($177M) in net income.
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($172M) | ($113M) | ($66M) | ($39M) | — |
| Net Income | ($177M) | ($112M) | ($64M) | ($40M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($50M) | ($49M) | ($43M) | ($44M) | ($36M) | — |
| Net Income | ($53M) | ($51M) | ($44M) | ($45M) | ($37M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $467M | $245M | $191M | $176M | — |
| Total Liabilities | $366M | $130M | $52M | $42M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CELC viewer.
About TickerBase · Data methodology & sources